Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's ...

Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...

In the quest for longevity and reversing biological age, Bryan Johnson, a tech entrepreneur known for his extensive efforts ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — ...

Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...